Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Monique de Visser"'
Autor:
Wim J.G. Oyen, Monique de Visser, Marion de Jong, Erik Vegt, Martin Gotthardt, Maarten Brom, Otto C. Boerman, Annemarie Eek, Marleen Melis
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 38, 4, pp. 623-32
European Journal of Nuclear Medicine and Molecular Imaging, 38(4), 623-632. Springer-Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 38, 623-32
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 38(4), 623-632. Springer, Cham
European Journal of Nuclear Medicine and Molecular Imaging, 38(4), 623-632. Springer-Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 38, 623-32
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 38(4), 623-632. Springer, Cham
Contains fulltext : 98302.pdf (Publisher’s version ) (Closed access) PURPOSE: Radiolabelled peptides used for peptide receptor radionuclide therapy are excreted mainly via the kidneys and are partly reabsorbed and retained in the proximal tubular c
Autor:
Erik Vegt, Magda Bijster, Marleen Melis, Mark Konijnenberg, Marcel Vermeij, Eric P. Krenning, Marion de Jong, Otto C. Boerman, Monique de Visser
Publikováno v:
Journal of Nuclear Medicine, 51(6), 973-977. Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (1978), 51, 973-7
The Journal of Nuclear Medicine (1978), 51, 6, pp. 973-7
The Journal of Nuclear Medicine (1978), 51, 973-7
The Journal of Nuclear Medicine (1978), 51, 6, pp. 973-7
Contains fulltext : 89547.pdf (Publisher’s version ) (Closed access) We determined the renal radiation dose of a series of (111)In-labeled peptides using animal SPECT. Because the animals' health deteriorated, renal toxicity was assessed. METHODS:
Autor:
Corrina M.A. de Ridder, Rogier P. J. Schroeder, Eric P. Krenning, Wout A.P. Breeman, Marleen Melis, Monique de Visser, Suzanne Reneman, Marion de Jong, Wytske M. van Weerden
Publikováno v:
International Journal of Cancer, 126(12), 2826-2834. Wiley-Liss Inc.
Human prostate cancer (PC) overexpresses the gastrin-releasing peptide receptor (GRPR). Radiolabeled GRPR-targeting analogs of bombesin (BN) have successfully been introduced as potential tracers for visualization and treatment of GRPR-overexpressing
Autor:
Otto C. Boerman, Eric P. Krenning, Marleen Melis, Marion de Jong, Monique de Visser, Magda Bijster, Edgar J. Rolleman, Jan de Swart, Mark Konijnenberg
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 36(12), 1968-1976. Springer-Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 36(12), 1968-1976. Springer-Verlag
Purpose Peptide receptor radionuclide therapy using β-emitting radiolabelled somatostatin analogues like DOTA,Tyr3-octreotate shows beneficial results in patients suffering from somatostatin receptor overexpressing tumours. However, after high-dose
Autor:
Marion de Jong, Annemarie C. Dechesne, Dirk T. S. Rijkers, Monique de Visser, Otto C. Boerman, Rob M. J. Liskamp, Cheng-Bin Yim
Publikováno v:
Bioconjugate Chemistry, 20, 7, pp. 1323-31
Bioconjugate Chemistry, 20(7), 1323-1331. American Chemical Society
Bioconjugate Chemistry, 20, 1323-31
Bioconjugate Chemistry, 20(7), 1323-1331. American Chemical Society
Bioconjugate Chemistry, 20, 1323-31
Contains fulltext : 80972.pdf (Publisher’s version ) (Closed access) The somatostatin analogue Tyr(3)-octreotide, which has a high binding affinity for the SSTR2 receptor (somatostatin receptor subtype 2) expressed on tumor cells, is used clinicall
Autor:
Monique de Visser, Buck E. Rogers, Jason S. Lewis, Marion de Jong, Jesse J. Parry, Gráinne B. Biddlecombe, Jack L. Erion
Publikováno v:
Bioconjugate Chemistry. 18:724-730
Bombesin is a tetradecapeptide neurohormone that binds to gastrin-releasing peptide receptors (GRPR). GRPRs have been found in a variety of cancers including invasive breast and prostate tumors. The peptide MP2346 (DOTA-(Pro(1),Tyr(4))-bombesin(1-14)
Autor:
Eric P. Krenning, Theo J. Visser, Magda Bijster, Bert F. Bernard, Marcel Vermeij, Edgar J. Rolleman, Jan Lindemans, Marion de Jong, Monique de Visser
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 34(2), 219-227. Springer-Verlag
Studies on peptide receptor radionuclide therapy (PRRT) using radiolabelled somatostatin analogues have shown promising results with regard to tumour control. The efficacy of PRRT is limited by uptake and retention in the proximal tubules of the kidn
Autor:
Otto C. Boerman, Eric P. Krenning, Saskia C. Berndsen, Marion de Jong, Roelf Valkema, Jan de Swart, Stuart Koelewijn, Monique de Visser, Marleen Melis
Publikováno v:
The Journal of Nuclear Medicine (1978), 51, 12, pp. 1962-8
The Journal of Nuclear Medicine (1978), 51, 1962-8
The Journal of Nuclear Medicine (1978), 51, 1962-8
Contains fulltext : 88816.pdf (Publisher’s version ) (Closed access) High kidney radiation doses during clinical peptide receptor radionuclide therapy (PRRT) with beta-particle-emitting radiolabeled somatostatin analogs will lead to renal failure s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7958bd42358508612138deb9e6936919
https://hdl.handle.net/2066/88816
https://hdl.handle.net/2066/88816
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals, 23(2), 137-157. Mary Ann Liebert Inc.
Somatostatin receptor-targeting peptides are widely used for the imaging and therapy of neuroendocrine tumors. Peptide-receptor radionuclide therapy (PRRT) in neuroendocrine tumor patients with radiolabeled somatostatin analogs has resulted in sympto
Autor:
Eric P. Krenning, Suzanne M. Verwijnen, Roelf Valkema, Marion de Jong, Dik J. Kwekkeboom, Monique de Visser
Publikováno v:
Targeted Radionuclide Tumor Therapy ISBN: 9781402086953
Somatostatin receptor-targeting peptides are widely being used for imaging and therapy of neuroendocrine tumors. Peptide receptor radionuclide therapy (PRRT) with e.g. 177Lu labeled somatostatin analogues in neuroendocrine tumor patients has resulted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df35de08ec393605ef45acf03160ec36
https://doi.org/10.1007/978-1-4020-8696-0_7
https://doi.org/10.1007/978-1-4020-8696-0_7